Biotech Reading List (August 2018)

Anarchist Drugs For All. Yeahboy.
Derek Lowe (In the Pipeline)
 
A Rare Genetic Aversion to Sweets Could Be Key to Fighting Obesity
Jared S Hopkins (Bloomberg)
 
The 41% Man: Perceptive Advisors’ Joseph Edelman regularly crushes
markets and hedge fund peers. How?
Amanda Cantrell (Institutional Investor)
 
CVS decides to make ICER an American NICE
Jonathon Gardner (Vantage)
 
Early-Stage Biotech Value Creation: The Roles of Equity and Partnerships
Steve Holtzman (Leadership and Biotechnology)
 
The difficult search for the right recipe in cancer immunotherapy
Lisa M Jarvis (C&E News)
 
A Harvard Scientist Thinks He Has a Gene Test for Heart Attack Risk. He Wants to Give It Away Free.
Matthew Herper (Forbes)